Botulinum Toxin Type E Completed Phase 2 Trials for Mohs Surgery Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03346902
Study of EB-001 in Facial Scar Reduction